New drug protects against diet-induced obesity and diabetes
- Details
- Category: Research
A recent EU-funded study by a Swiss-led international team of researchers has found that a new synthetic drug, developed by researchers in the US, protects against diet-induced obesity. At the same time, it improves glucose tolerance and insulin sensitivity and increases exercise endurance by enhancing fat utilisation in certain tissues.
Manhattan Research reports that the number of Health 2.0 consumers has doubled since 2007
- Details
- Category: Research
Over 60 million U.S. adults are Health 2.0 consumers - reporting to use health blogs, online support groups, prescription rating sites, and other health-related social media applications, according to pharmaceutical and healthcare market research company Manhattan Research's just released Cybercitizen Health™ v8.0 consumer study and strategic advisory service.
New finding could lead to development of hundreds of new antibiotics
- Details
- Category: Research
EU-funded scientists have discovered a new molecule in Streptomyces bacteria that could be exploited to make the bacteria produce hundreds of novel antibiotics. The work, which is published online by the Proceedings of the National Academy of Sciences (PNAS), was partly supported by the EU-funded ACTINOGEN (Integrating genomics-based applications to exploit actinomycetes as a resource for new antibiotics) project.
Heinrich Wieland Prize: Closing in on the cause of diabetes
- Details
- Category: Research
For his milestone discoveries on the development of diabetes, Prof. Markus Stoffel from the Institute of Molecular Systems Biology at the ETH Zurich was awarded the Heinrich Wieland Prize, one of the most treasured science awards in Germany. He received the distinction with EUR 50,000 prize money for his work in deciphering important mechanisms of blood sugar regulation and lipid metabolism in the body.
InforSense Collaborates with Industry Innovators to Enable Virtual Drug Discovery
- Details
- Category: Research
InforSense Ltd., the leading provider of next generation business and scientific intelligence tools, has successfully completed a pilot project at world leading pharmaceutical company GlaxoSmithKline (GSK) to enable virtual drug discovery through virtual outsourcing of data analysis via secure Grid technology.
Research agreement for the development of insulin-producing cells from human stem cells
- Details
- Category: Research
Novo Nordisk A/S, a world leader in diabetes care, Cellartis AB, a forefront stem cell biotechnology company, and Lund University Stem Cell Center today signed a collaborative research agreement for the development of insulin-producing cells from human stem cells.
A new journal where molecular biology meets clinical research
- Details
- Category: Research
The European Molecular Biology Organization (EMBO) has announced the introduction of EMBO Molecular Medicine, a new journal dedicated to a research discipline focused on the interface between molecular biology and clinical research. The new journal, launching in 2009, will publish original research offering molecular insights into cellular and systemic processes underlying defined human diseases as well as potential clinical applications for diagnosis, prevention and therapy.
More Pharma News ...
- EMEA half-year report for 2008 shows activities to be on target
- New Media Offers Cost-Efficient Ways to Reach and Engage Targets
- Medicines regulators on both sides of the Atlantic confirm commitment to cooperation on medicines
- Philips develops ultrasound-activated microbubbles for localized delivery of cancer drugs
- Pharmaceutical Forum Concluded Successfully
- FDA Analysis on Cholesterol Lowering Medications
- Life Competence - the first global picture on the EU-funded health research